Business Context and Reporting Period
This Form 8-K filing by Kimberly-Clark Corporation (KMB) reports on the results of the 2025 Annual Meeting of Stockholders held on May 1, 2025. The filing details the voting outcomes for director elections, auditor ratification, and executive compensation.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent 10-Q or 10-K filings for financial statements.
Material Changes and Voting Results
The filing reports the final voting results for three key matters submitted to stockholders:
- Election of Directors: All 14 nominees were elected. While most directors received overwhelming support, two nominees received significant "Against" votes:
- Michael D. Hsu: 15,872,619 votes against (approx. 6.5% of total votes cast).
- Dunia A. Shive: 8,237,929 votes against (approx. 3.4% of total votes cast).
- Mark T. Smucker: 3,875,197 votes against (approx. 1.6% of total votes cast).
- Ratification of Independent Auditors: Stockholders ratified the selection of Deloitte & Touche LLP for 2025.
- Votes For: 267,219,914
- Votes Against: 19,961,479
- Advisory Approval of Executive Compensation: Stockholders approved the compensation of named executive officers.
- Votes For: 226,830,430
- Votes Against: 17,437,076
Guidance, Outlook, and Risks
This filing does not provide management commentary, financial guidance, outlook, or specific risk factors. It strictly reports the administrative outcomes of the annual meeting.
Key Facts for Investor Verification
- Verify the reasons behind the elevated "Against" votes for directors Michael D. Hsu and Dunia A. Shive, as these dissent levels are notably higher than for other nominees.
- Confirm the total number of shares outstanding and the percentage of shares represented at the meeting to contextualize the broker non-votes (41,889,391).
- Review the company's proxy statement (DEF 14A) for detailed biographies of the directors and the specific rationale for the executive compensation package approved.